From licensing activity to pricing behavior, three emerging patterns from 2025 offer a clearer picture for the New Year.

Cannabis investors may be feeling bullish entering 2026 after marijuana rescheduling, but some more advances are needed for ...

Marijuana rescheduling isn't official yet. Here's what needs to happen for cannabis to be downgraded under federal law.

Held back for decades, cannabis research is a central part of marijuana rescheduling. But some questions remain.

The Cannabist Co. will sell its vertically integrated permit in Virginia to a Boston-based hedge fund rather than competing ...

Cannabis business owner Wanda James is singing a familiar tune – one that fans of Jamaican reggae singer Peter Tosh know well: “Legalize it.” ...

Cannabis' sworn enemy revealed itself to be behind the voter initiative campaigns seeking to roll back $1.9 billion in annual sales.

President Donald Trump's order to reclassify cannabis as a Schedule 3 drug is a huge step forward - but operators must know its limits.

With President Donald Trump’s executive order to reschedule cannabis, businesses in the industry are rolling out their growth strategies.

Potency testing on store-bought cannabis flower by a Canadian laboratory has found THC levels significantly lower than the labeled value, sparking an industrywide conversation about how to address ...

Specialty marijuana finance company Chicago Atlantic Real Estate Finance closed on a $50 million loan to fund future investments and other corporate purposes. Chicago Atlantic, an Illinois-based ...

The California Department of Cannabis Control revoked a commercial testing laboratory’s permit a month ago after tests at state-run labs discovered a harmful pesticide in marijuana the private lab had ...